Qube Research & Technologies (QRT)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,477	Closed	-$47.6K	–	3157
2022 Q4	$47.6K	Buy	1,477 +493	+50%	+$19.5K	﹤0.01%	2144
2022 Q3	$41K	Sell	984 -554	-36%	-$25.3K	﹤0.01%	2181
2022 Q2	$65K	Buy	+1,538	New	+$71.3K	﹤0.01%	2069
2020 Q4	–	Sell	-527	Closed	-$56K	–	2305
2020 Q3	$56K	Buy	+527	New	+$48K	﹤0.01%	1538

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVLO Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2023, closing a stake of 1,477 shares — an estimated $47.6K sold.

Qube Research & Technologies (QRT) first reported a position in EVLO in Q3 2020 and held it in 4 quarters. The position peaked at $65K in Q2 2022. 39 funds tracked by Wall St. Rank hold EVLO as of Q1 2023.

Qube Research & Technologies (QRT) reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,477 Evelo Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $47.6K.
Qube Research & Technologies (QRT) first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Evelo Biosciences, Inc. Common Stock position peaked at $65K in Q2 2022.
39 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.